JPH11511136A - 癌の成長を阻害するためのグリセオフルビンの使用 - Google Patents

癌の成長を阻害するためのグリセオフルビンの使用

Info

Publication number
JPH11511136A
JPH11511136A JP9508495A JP50849597A JPH11511136A JP H11511136 A JPH11511136 A JP H11511136A JP 9508495 A JP9508495 A JP 9508495A JP 50849597 A JP50849597 A JP 50849597A JP H11511136 A JPH11511136 A JP H11511136A
Authority
JP
Japan
Prior art keywords
treating
cancer
griseofulvin
pharmaceutical composition
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP9508495A
Other languages
English (en)
Japanese (ja)
Inventor
カムデン，ジェイムズ，バーガー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of JPH11511136A publication Critical patent/JPH11511136A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP9508495A 1995-08-03 1996-07-30 癌の成長を阻害するためのグリセオフルビンの使用 Pending JPH11511136A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US183995P 1995-08-03 1995-08-03
US67418196A 1996-07-16 1996-07-16
US08/674,181 1996-07-16
US60/001,839 1996-07-16
PCT/US1996/012475 WO1997005870A2 (en) 1995-08-03 1996-07-30 Use of griseofulvin for inhibiting the growth of cancers

Publications (1)

Publication Number Publication Date
JPH11511136A true JPH11511136A (ja) 1999-09-28

Family

ID=26669547

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9508495A Pending JPH11511136A (ja) 1995-08-03 1996-07-30 癌の成長を阻害するためのグリセオフルビンの使用

Country Status (16)

Country Link
EP (1) EP0841914A2 (es)
JP (1) JPH11511136A (es)
KR (1) KR19990036137A (es)
AR (1) AR003176A1 (es)
AU (1) AU713031B2 (es)
BR (1) BR9609920A (es)
CA (1) CA2228503A1 (es)
CZ (1) CZ30598A3 (es)
HU (1) HUP9903506A3 (es)
IL (1) IL123094A0 (es)
MX (1) MX9800945A (es)
NO (1) NO980420L (es)
PL (1) PL324905A1 (es)
SK (1) SK14298A3 (es)
TR (1) TR199800244T2 (es)
WO (1) WO1997005870A2 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6177460B1 (en) 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US6686391B2 (en) 1995-08-04 2004-02-03 University Of Arizona Foundation N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
DK1098641T3 (en) * 1998-07-27 2016-08-15 St Jude Pharmaceuticals Inc Chemically induced intracellular hyperthermia
AU761844C (en) 1998-11-09 2004-09-23 F. Hoffmann-La Roche Ag Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-CD20 antibody
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
CN1543356B (zh) * 2001-06-25 2011-09-28 味之素株式会社 抗肿瘤剂
EP2008652A1 (en) * 2007-06-28 2008-12-31 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering
EP2204367A1 (en) 2008-12-22 2010-07-07 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering

Also Published As

Publication number Publication date
AU6683496A (en) 1997-03-05
KR19990036137A (ko) 1999-05-25
SK14298A3 (en) 1998-09-09
HUP9903506A2 (hu) 2000-06-28
IL123094A0 (en) 1998-09-24
AU713031B2 (en) 1999-11-18
NO980420L (no) 1998-04-03
CA2228503A1 (en) 1997-02-20
TR199800244T2 (xx) 1998-09-21
NO980420D0 (no) 1998-01-30
WO1997005870A2 (en) 1997-02-20
MX9800945A (es) 1998-04-30
AR003176A1 (es) 1998-07-08
EP0841914A2 (en) 1998-05-20
HUP9903506A3 (en) 2000-07-28
PL324905A1 (en) 1998-06-22
BR9609920A (pt) 1999-07-06
CZ30598A3 (cs) 1998-06-17
WO1997005870A3 (en) 1997-04-17

Similar Documents

Publication Publication Date Title
EP0956017B1 (en) Benzimidazole-2-carbamates for the treatment of viral infections and cancer
EP0821586B1 (en) A pharmaceutical composition containing benzimidazole for inhibiting the growth of cancers
JPH11511136A (ja) 癌の成長を阻害するためのグリセオフルビンの使用
JPH11510187A (ja) 癌の成長を阻害するためのフルコナゾールの使用
US6251870B1 (en) Pharmaceutical composition for inhibiting growth of cancers
MXPA98000998A (es) Uso de fluconazol para inhibir el crecimiento de canceres
US6200992B1 (en) Pharmaceutical composition for inhibiting the growth of cancers
MXPA98000945A (es) Uso de griseofulvina para inhibir el crecimientode canceres
US5908855A (en) Compositions for treating viral infections
MXPA97007809A (es) Una composicion farmaceutica que contiene bencimidazol para inhibir el crecimiento de canceres
MXPA98000944A (es) Uso de derivados de 1h-1,2,4-triazol para inhibirel crecimiento de canceres
US20010041678A1 (en) Compositions and methods for treating cancer
MXPA97007808A (es) Una composicion farmaceutica que contiene n-clorofenilcarbamatos y n-clorofiniltiocarbamatos para inhibir el crecimiento de virus y canceres
AU730920B2 (en) A pharmaceutical composition containing N-chlorophenylcarbamates and N-chlorophenylthiocarbamates for inhibiting the growth of viruses and cancers
MXPA97007810A (es) Una composicion farmaceutica que contiene derivados de n-fosfonoglicina para inhibir el crecimientode virus y canceres